|
Volumn 20, Issue 10, 2012, Pages 3233-3241
|
Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents
|
Author keywords
2* 6 Dinitro 4 (trifluoromethyl)phenoxysalicylaldoxime derivatives; Antitubulin polymerization; Molecular docking; Structure activity relationship
|
Indexed keywords
2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 CHLOROBENZYL)OXIME;
2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 FLUOROBENZYL)OXIME;
2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2,4 DICHLOROBENZYL)OXIME;
2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O BENZYLOXIME;
2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXYSALICYLALDOXIME DERIVATIVE;
3,5 DIBROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 CHLOROBENZYL)OXIME;
3,5 DIBROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 FLUOROBENZYL)OXIME;
3,5 DIBROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2,4 DICHLOROBENZYL)OXIME;
3,5 DIBROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O BENZYLOXIME;
3,5 DICHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 CHLOROBENZYL)OXIME;
3,5 DICHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 FLUOROBENZYL)OXIME;
3,5 DICHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2,4 DICHLOROBENZYL)OXIME;
3,5 DICHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O BENZYLOXIME;
5 BROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 CHLOROBENZYL)OXIME;
5 BROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 FLUOROBENZYL)OXIME;
5 BROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2,4 DICHLOROBENZYL)OXIME;
5 BROMO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O BENZYLOXIME;
5 CHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 CHLOROBENZYL)OXIME;
5 CHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2 FLUOROBENZYL)OXIME;
5 CHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O (2,4 DICHLOROBENZYL)OXIME;
5 CHLORO 2 [2,6 DINITRO 4 (TRIFLUOROMETHYL)PHENOXY]BENZALDEHYDE O BENZYLOXIME;
COLCHICINE;
SALICYLALDOXIME;
TUBULIN;
UNCLASSIFIED DRUG;
ANTIPROLIFERATIVE ACTIVITY;
APOPTOSIS;
ARTICLE;
BINDING SITE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IC 50;
MOLECULAR DOCKING;
PROTEIN POLYMERIZATION;
APOPTOSIS;
BINDING SITES;
CELL LINE, TUMOR;
CELL PROLIFERATION;
COMPUTER SIMULATION;
DRUG SCREENING ASSAYS, ANTITUMOR;
FLOW CYTOMETRY;
FLUORINE;
HUMANS;
INHIBITORY CONCENTRATION 50;
MAGNETIC RESONANCE SPECTROSCOPY;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
OXIMES;
POLYMERIZATION;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUBULIN MODULATORS;
|
EID: 84860486758
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.03.057 Document Type: Article |
Times cited : (24)
|
References (32)
|